Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metformin for knee osteoarthritis in adults with overweight or obesity
ACTRN12621000710820Phase 3Completed
- Sponsor
- Flavia Cicuttini
- Start
- Dec 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in knee osteoarthritis (OA) comparing Metformin with Placebo (2 arms). Primary endpoint: Change in visual analogue scale knee pain. Started Dec 2021; status: completed.
02
Drugs
metformin
03
Conditions
knee osteoarthritis (OA)
Beyond the preview
Go deeper on ACTRN12621000710820.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12621000710820.